| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |